Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion

Spine

Volumn 35, Issue 20, 2010, Pages

  Jenis, Louis G ^a   Banco, Robert J ^a  

^a Boston Spine Group   (United States)

Author keywords

bone graft substitute; posterolateral lumbar fusion; radiographic outcomes; silicate substituted ceramic

Indexed keywords

CALCIUM PHOSPHATE CERAMIC; SILICATE;

ADULT; ARTICLE; BACKACHE; BONE GRAFT; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ILIAC CREST; LAMINECTOMY; LEG PAIN; LUMBAR SPINE; MALE; OUTCOME ASSESSMENT; POSTEROLATERAL INSTRUMENTED LUMBAR FUSION; PRIORITY JOURNAL; RADIOGRAPHY; SPINE FUSION; SURGICAL TECHNIQUE;

AGED; AGED, 80 AND OVER; CALCIUM PHOSPHATES; CERAMICS; DURAPATITE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOGENESIS; OSTEOLYSIS; PAIN; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SILICATES; SPINAL FUSION; TREATMENT OUTCOME;

EID: 77957369044     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181df196f     Document Type: Article

References (28)

1. Dai L, Jiang L. Single level instrumented posterolateral fusion of the lumbar spine with beta tricalcium phosphate versus autograft: a prospective, randomized study with three-year follow up. Spine 2008;33:1299-304.
2. Epstein N. An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate. Spine J 2008;8:882-7.
3. Epstein N. Beta tricalcium phosphate: observation of use in 100 posterolateral lumbar instrumented fusions. Spine J 2009;9:630-8.
4. Korovessis P, Koureas G, Zacharatos C, et al. Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft vs. corraline hydroxyapatite. Eur Spine J 2005;14:630-8.
5. Acharya N, Kumar R, Varma H, et al. Hydroxyapatite-bioactive glass ceramic composite as stand-alone graft substitute for posterolateral fusion of the lumbar spine: a prospective, matched and controlled study. J Spinal Disord Tech 2008;21:106-11.
6. Moro-Barrero L, Acebal-Cortina G, Suarez-Suarez M, et al. Radiographic analysis of fusion mass using fresh autologous bone marrow with ceramic composites as an alternative to autologous bone graft. J Spinal Disord Tech 2007;20:409-15.
7. Thalgott J, Giuffre J, Fritts K, et al. Instrumented posterolateral lumbar fusion using coralline hydroxyapatite with or without demineralized bone matrix, as an adjunct to autologous bone. Spine J 2001;1:131-7.
8. Fujibayashi S, Shikata J, Tanaka C, et al. Lumbar posterolateral fusion with biphasic calcium phosphate ceramic. J Spinal Disord Tech 2001;14:214-21.
9. Lee KY, Park M, Kim HM, et al. Ceramic bioactivity: progress, challenges and perspectives. Biomed Mater 2006;1:31-7.
10. Carlisle E. Silicon as an essential element. Fed Proceed 1974;33:1758-66.
11. Gibson I, Hing K, Revell P, et al. Enhanced in vivo response to silicate-substituted hydroxyapatite. Key Eng Mater 2002;218-20:203-6.
12. Muller W, Boreiko A, Wang X. Morphogenetic analysis of silica and bio-silica on the expression of genes controlling biomineralization using SaOS-2 cells. Calcif Tissue Int 2007;81:382-93.
13. Guth K, Buckland T, Hing H. Silicon dissolution from micro porous silicon substituted hydroxyapatite and its effect on osteoblast behavior. Key Eng Mater 2006;309-11:117-20.
14. Carreon L, Djurasovic M, Glassman S, et al. Diagnostic accuracy and reliability of fine cuts CT scans with reconstructions to determine the status of an instrumented posterolateral fusion with surgical exploration as reference standard. Spine 2007;32:892-5.
15. Glassman S, Polly D, Bono C, et al. Outcome of lumbar arthrodesis in patients sixty-five years of age or older. J Bone Joint Surg 2009;91:783-90.
16. Sengupta D, Truumees E, Patel C, et al. Outcome of local bone versus autologous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine. Spine 2006;31:985-91.
17. Deguchi M, Rapoff A, Zdeblick T. Posterolateral fusion for isthmic spondylolisthesis in adults: analysis of fusion rate and clinical results. J Spinal Disord Tech 1998;11:459-464.
18. Dimar J, Glassman S, Burkus K, et al. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthodesis. J Bone Joint Surg 2009;91:1377-86.
19. Dimar J, Glassman S, Burkus K, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenic protein 2/compression resistant matrix versus iliac crest bone graft. Spine 2006;31:2534-9.
20. Kanayama M, Hashimoto T, Shigenobu K, et al. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute. Spine 2006;31:1067-74.
21. Vaccaro A, Lawrence J, Patel T, et al. The safety and efficacy of OP-1 (rh-BMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis. A long term (>4 years) pivotal study. Spine 2008;33:2850-62.
22. Cammisa F, Lowery G, Garfin S, et al. Two year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral lumbar fusion: a prospective controlled trial employing a side by side comparison in the same patient. Spine 2004;29:660-9.
23. Chen W, Tsai T, Chen L, et al. The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion. Spine 2005;30:2293-7.
24. Fernandez-Fairen M, Sala P, Ramirez H, et al. A prospective randomized study of unilateral versus bilateral instrumented posterolateral lumbar fusion in degenerative spondylolisthesis. Spine 2007;32:395-401.
25. Papakostidis C, Kontakis G, Bhandari M, et al. Efficacy of autologous iliac crest bone graft and bone morphogenic proteins for posterolateral fusion of the lumbar spine. A meta-analysis of results. Spine 2008;33:E680-92.
26. LeGeros R. Properties of osteoconductive materials: calcium phosphates. Clin Orthop Relat Res 2002;395:81-98.
27. Patel N, Brooks R, Clarke M, et al. In vivo assessment of hydroxyapatite and silicate substituted hydroxyapatite granules using an ovine defect model. J Mater Sci 2005;16:429-40.
28. Wheeler D, Jenis L, Kovach M, et al. Efficacy of silicated calcium phosphate graft in posterolateral lumbar fusion in sheep. Spine J 2007;7:308-17.